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Abstract
Background: To propose a new diagnostic algorithm for candidates for Fontan and identify those who can skip
cardiac catheterization (CC).
Methods: Forty-four candidates for Fontan (median age 4.8 years, range: 2-29 years) were prospectively evaluated
by trans-thoracic echocardiography (TTE), Cardiovascular magnetic resonance (CMR) and CC. Before CC, according
to clinical, echo and CMR findings, patients were divided in two groups: Group I comprised 18 patients deemed
suitable for Fontan without requiring CC; group II comprised 26 patients indicated for CC either in order to detect
more details, or for interventional procedures.
Results: In Group I ("CC not required”) no unexpected new information affecting surgical planning was provided
by CC. Conversely, in Group II new information was provided by CC in three patients (0 vs 11.5%, p = 0.35) and in
six an interventional procedure was performed. During CC, minor complications occurred in one patient from
Group I and in three from Group II (6 vs 14%, p = 0.7). Radiation Dose-Area product was similar in the two groups
(Median 20 Gycm
2, range: 5-40 vs 26.5 Gycm
2, range: 9-270 p = 0.37). All 18 Group I patients and 19 Group II
patients underwent a total cavo-pulmonary anastomosis; in the remaining seven group II patients, four were
excluded from Fontan; two are awaiting Fontan; one refused the intervention.
Conclusion: In this paper we propose a new diagnostic algorithm in a pre-Fontan setting. An accurate non-
invasive evaluation comprising TTE and CMR could select patients who can skip CC.
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Background
In patients with a functional single ventricle, a staged
surgical approach leading to a Fontan procedure has
substantially improved life expectancy and functional
status [1,2]. Before Fontan, cardiac catheterization (CC)
is routinely indicated to detect the suitability for and
risks of Fontan [3] or to identify patients who require
additional interventions (either by catheter before sur-
gery or in the operating room concomitant with the
Fontan procedure) [4]. However, CC is an invasive tool
associated with morbidity and mortality [5-7] and uses
ionizing radiation, increasing the patient’s long-term risk
of cancer [8,9]. Transthoracic Echocardiography (TTE)
is widely used in such patients, but in the majority of
patients it is not sufficiently exhaustive for a complete
assessment of intracardiac and mediastinal vessel anat-
omy [3,10]. As highlighted by Banka et al. [11], a more
comprehensive imaging strategy not based solely on
echocardiography should be considered. Cardiovascular
Magnetic Resonance (CMR) has gained widespread
acceptance in the evaluation of pre- and post-operative
congenital heart disease [12], including patients with
univentricular circulation [13,14]. A randomized study
showed that CMR is a safe and cost-effective alternative
to catheterization in selected patient candidates for uni-
ventricular surgical palliation, before performing
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any medium, provided the original work is properly cited.bidirectional Glenn as a first step [15]. Previous retro-
spective studies also suggest that CC could be avoided
before Fontan in a certain percentage of patients with-
out adversely affecting outcome [4,16]. Prakash et al.
have recently proposed a new diagnostic algorithm to
avoid CC in ‘’low-risk’’ subjects before a Fontan opera-
tion [16]. Our hypothesis is that a “one-fits-all”
approach can be misleading in Fontan candidates, who
may benefit most from a tailored approach, restricting
CC only to a subset of patients in whom a combined
clinical, TTE and CMR approach is inadequate. To test
this hypothesis, we initiated a prospective, observational,
single-center study, systematically evaluating all Fontan
candidates by means of clinical, non-invasive (TTE,
CMR) and CC evaluation, in order to propose a tailored
diagnostic algorithm and to define patients who could
skip CC.
Method
From June 2002 to March 2011, all candidates for the
Fontan operation presenting at the Massa Heart Hospi-
tal were prospectively enrolled in this study approved by
the ethical committee of our institute. Informed consent
was obtained from all parents or legal guardians. All
patients (n = 44, median age 4.8 years, range 2-29)
resulted eligible for the study. Demographic and clinical
features are detailed in Table 1. Major extracardiac
disorders were hydrocephalus with myelomenigocele in
one patient and right lung hypoplasia in the context of a
scimitar syndrome in a second patient.
Study protocol
Histories including surgical and catheterization proce-
dures were retrospectively recorded. All patients were
then prospectively evaluated clinically and by laboratory
setup including TTE, CMR and CC.
Echocardiography: a standard comprehensive TTE
exam was performed with an appropriate probe (3 or 5
MHz) according to body weight. Cardiovascular anat-
omy and function were evaluated including assessment
of interatrial and ventricular septum, atrio-ventricular
valve morphology and function, pulmonary and systemic
venous return, superior cavo-pulmonary anastomosis
and pulmonary artery anatomy and flow pattern, ventri-
cular anatomy and function (based on visual quantifica-
tion), and systemic pathway (outflow tract, aortic valve
and aortic arch) anatomy and flow (See Table 2). If an
echo did not cover all the abovementioned features it
was considered not completed.
CMR
All examinations were performed using an Signa/GE CV/i
1,5 T scanner (maximal gradient = 40 mT/m, slew rate =
150 mT/m/sec) with a surface 4-channel cardiac phased-
array coil (8-channel from 2005). A comprehensive CMR
Table 1 Demographic, history and clinical data
All (44 pts) Group 1 (18 pts) Group 2 (26 pts) P
Age at enrollment (years) 4.8 (2-29) 4.7 (2.7-13.6) 5 (2-29) 0.7
Weight at enrollment (Kg)
BSA at enrollment (m
2)
17 (12-76)
0.72 (0.5-1.8)
19 (14-36)
0.72 (0.6- 1.17)
17 (12-76)
0.71 (0.55-1.8)
0.6
0.3
Diagnosis:
HLHS 6 0 6
TA 9 6 3
Ebstein 2 2 0
DILV 5 2 3
Single right ventricle 3 2 1
Unbalanced AV canal 6 . 6
Complex 2 ventricles 13 6 7
Previous CC 41 18 23
Previous surgery 42 17 25
Aorto-pulmonary shunt 20 10 10
Pulmonary artery banding 10 2 8
Cavo-Pulm. Anastomosis 41 17 24
Atrioseptectomy 14 5 9
Norwood 60 6
Other
§ 81 7
Antegrade pulmonary flow 17 8 9
Peripheral O2 sat (%) 81 ± 5.8 82 ± 5.8 81 ± 5.9 0.6
Age, weight and BSA are expressed as median and range.
§ Other procedures: 1 tricuspid valve surgical closure, 2 aortic coarctatectomies, 2 total anomalous
venous return corrections, 1 ventricular septal defect enlargement, 2 surgical occlusions of significant veno-venous collaterals. AV: atrioventricular; BSA: body
surface area; CC: cardiac catheterization; DILV: double inlet left ventricle; HLHS: hypoplastic left heart syndrome; Sat: saturation. TA: Tricuspid atresia
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dedicated protocol [17]. Briefly, a preliminary 2D axial
“Time of flight” (TOF) acquisition prepared with a stack
of thin (3-mm) intersected slices covering the entire
thorax from the aortic arch down to slightly below the
diaphragm is prescribed. Further steps are: ECG-gated
cine Steady State Free Precession (SSFP) sequences to
visualize the ventricular/s anatomy and for quantitative
assessment of ventricular dimensions, function, mass and
stroke volume. SSFP sequences are also used to visualize
Table 2 ECHO, CMR and CC data and comparison between the two groups
All
(44 pts)
Group 1
(18 pts)
Group 2
(26 pts)
P
Echo AV valve regurgitation:
- Absent/trivial 20 10 10
- Mild/Moderate 18 8 10
- Severe 6 0 6
ASD:
- Large 37 13 24
- Restrictive/absent 4 4 0
- Not visualized 3 1 2
Ventricular function:
- Normal 41 18 23
- Mild/moderate dysfunction 2 0 2
- Severe dysfunction 1 0 1
Systemic obstruction 505
Right pulmonary artery
- Not visualized 18 5 13
- Stenosis/hypoplasia 3 1 2
Left pulmonary artery
- Not visualized 29 7 22
- Stenosis/hypoplasia 2 1 1
Superior vena cava
- Not visualized 7 1 6
CMR End ventricular vol. (ml/m
2) 106 ± 28 97 ± 23 112 ± 30 0.1
Ventricular EF (%) 61 ± 9.3 64.5 ± 8.5 58 ± 8.9 0.003
RPA diameter (mm) 12 (6-25) 13 (8-24) 11 (8-21) 0.25
LPA diameter (mm) 10.5 (5-23) 11.5 (8-22) 9 (5-23) 0.1
McGoon index 1.98 (1.1-3.4) 2.1 (1.58-2.8) 1.9 (1.1-3.4) 0.8
Nakata index (mm
2/m
2) 237 (107-654) 236 (146-567) 241(107-654) 0.85
RPA flow (ml/min) 886 (195-3815) 788 (195-3815) 972 (325-2352) 0.9
RPVs flow (ml/min)* 1573 (900-3900) 1712 (1033-3900) 1403 (900-3100) 0.3
LPA flow (ml/min) 732 (100-1858) 765 (263-1858) 467 (100-1463) 0.1
LPV vein flow (ml/min)* 1185 (583-2500) 1250 (745-2360) 1120 (583-2500) 0.6
CC Radiation DAP (Gycm
2) 21.6 (5-270) 20 (5-40) 26.5 (9-270) 0.35
Minor Complications 4 1 3 0.8
RPA pressure (mmHg) 12.2 ± 2.98 11.2 ± 2.4 13.1 ± 3.4 0.04
LPA (mmHg) 11.7 ± 3 10.8 ± 2 12.4 ± 3.3 0.05
SVC pressure (mmHg) 12.8 ± 3 11.3 ± 2.5 13.5 ± 2.5 0.01
Atrial pressure (mmHg) 8.1 ± 2.2 7.7 ± 2.3 8.5 ± 2.2 0.2
End ventricular pressure (mmHg) 8.8 ± 2.3 8.5 ± 2.3 9.1 ± 2.3 0.3
PVR (UI/m
2) 1.75 ± 0.6 1.55 ± 0.6 1.84 ± 0.46 0.08
McGoon index 1.95 ± 0.47 1.97 ± 0.4 1.92 ± 0.5 0.7
Nakata index (mm
2/m
2) 275 (77-1044) 325 (158-1044) 257(77-586) 0.3
Mayo clinic index 2.93 ± 0.94 2.75 ± 1,15 3 ± 0.8 0.9
Continuous data are expressed as mean ± SD and as median and range depending upon the normality of the data. * Assessed in the last 21 patients
Legend: ASD: atrial septal defect; DAP: Dose Area Product; Ed: End-diastolic; EF: ejection fraction ; LPA: left pulmonary artery; LPVs: left pulmonary veins; PVR:
pulmonary vascular resistance; RPA: right pulmonary artery; RPVs: right pulmonary veins; SVC: superior vena cava
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relationship to the AV and VA valves, ventricular outflow
tract/s and pulmonary branches. ECG-gated phase-velo-
city-contrast (PVC-CMR) free-breathing sequences per-
pendicular to the main pulmonary artery (if present),
ascending aorta, pulmonary arteries, and systemic veins.
S i n c e2 0 0 5t h ep u l m o n a r yv e in flow was also assessed.
PVC-CMR sequence parameters were: echo time: 3.7 ms;
repetition time 6.2 ms; Flip Angle 20°; slice thickness 5
mm; field of view from 320 to 380 mm; matrix size 192
x140; trigger delay minimum; views per segment 2; Velo-
city encoding (VENC) according to excepted flow velocity.
SSFP sequence parameters were: echo time: 1.4 ms; repeti-
tion time 3.5 ms; Flip Angle 60°, slice thickness 6-7 mm
with no interslice gap; field of view from 320 to 380 mm;
matrix size 224x224; trigger delay minimum; views per
segment 8-14 according to heart rate, number of excita-
tion 1 up to 3 if under sedation. The CMR exam was com-
pleted by a contrast-enhanced (gadopentate dimeglumine
0.4 ml/kg) three-dimensional Magnetic Resonance Angio-
graphy (MRA) finalized to the visualization (together with
TOF acquisition) of the mediastinal vessels, as well as
potential aorto-pulmonary and veno-venous collaterals;
technical parameters were set as follows: echo time 1.1
ms; repetition time 3.5 ms; Flip Angle 20°, slice thickness
2.6 mm with no interslice gap; field of view from 320 to
380 mm and locs for slab 60; data matrix size 224 × 192;
acquired to fill center lines and center slices of K-space
first.
In patients studied in recent years the Late Gadoli-
nium Enhancement (LGE) technique was added to the
abovementioned protocol, in order to detect potential
myocardial fibrous tissue [18]. In 36 patients < 8 years
old and/or in patients who did not tolerate the CMR
exam, it was performed with the patient deeply sedated
by means of titrated propofol, and sequences were
acquired as free-breathing.
Left and right pulmonary artery (LPA and RPA) dia-
meter and area were calculated from MRA. The Nakata
index [19], and Mac Goon index [20] were also respec-
tively assessed as follows: LPA area + RPA area/BSA;
LPA Ø + RPA Ø/Diaphragmatic Aorta Ø.
Cardiac catheterization
All procedures were performed using the Philips Integris
H5000C Monoplane with the × Ray tube MRC 200 0508
ROT GS 1001. The anatomy of the pulmonary branches,
aorta, superior and inferior vena cava and the aortic
arch were evaluated by X-ray angiography in the AP
plane and other appropriate planes if required, taking
care to visualize potential aorto-pulmonary and/or veno-
venous collaterals. A ventriculography was also per-
formed to evaluate ventricular function. The pullback
pressure was recorded in the pulmonary arteries, aorta,
aortic arch, superior and inferior vena cava and in the
ventricle. In case of suspected dynamic sub-aortic
obstruction an Isoprenaline test was performed. Pul-
monary vascular resistance and Mayo clinic index were
calculated when possible. The latter was calculated as
described [21]: adding pulmonary artery resistance to
left ventricular end-diastolic pressure divided by Qp
plus Qs where Qp and Qs are pulmonary and systemic
blood flow respectively indexed to body surface area;
The Nakata index [19], and Mac Goon index [20] were
also respectively assessed as indicated above. Intra- and
post-procedural complications were recorded. All proce-
dures were performed with endotracheal intubation,
under anesthesia.
The patients’ history, physical examination, TTE and
C M Rd a t aw e r ea n a l y z e db ya ne x p e r i e n c e dp e d i a t r i c
cardiologist (PF) and cardiac surgeon (BM) before per-
forming CC and the patients were divided into two
groups: Group 1: individuals with exhaustive pre-opera-
tive information in whom CC could be avoided ("CC
not required” group); Group II: patients with indications
for cardiac catheterization ("CC required” group).
Evaluation criteria for the patient group selection
(hence for CC indication) were: 1) severe atrio-ventricu-
lar valve regurgitation semi-quantitatively evaluated by
means of echo color Doppler 2) Ventricular EF < 50%.
3) Suspected pulmonary vein stenosis at echo and/or
CMR. 4) Suspected systemic obstruction evaluated as
follow: VSD flow velocity at echo-color Doppler > 2 m/
s; aortic arch or isthmus narrowing < 40% of abdominal
aorta diameter at CMR and/or flow velocity > 3 m/sec
at echo-color Doppler. 5) Suspected pulmonary pathway
or Glenn anastomosis obstruction evaluated as a dia-
meter narrowing at MRA < 25% of the adjacent seg-
ment. 6) Complicated post-Glenn course: low cardiac
output (defined as high or increasing plasma lactate and
low mixed venous oxygen saturation) or prolonged
pleural drainage (> 10 days). 7) Suspected significant
veno-venous collaterals at MRA or when peripheral O2
saturation is less than 75%. 8) Presence of or suspected
aorto-pulmonary collaterals at MRA and/or at echo. 9)
Contradictory or incomplete clinical-instrumental find-
ings. 10) Indications for interventional procedures.
By study design all patients of both groups underwent
CC. (See Table 1 for demographic-clinical data and
Table 2 for echo, CMR and CC data). Two patients
evaluated in the last part of the study, categorized as
group 1, were operated for Fontan without previous CC,
according to the parents’ wishes.
Statistical analysis
Continuous data are expressed as mean ± SD and as
median and range as appropriate. Inter-group compari-
sons were performed using the unpaired Student’st - t e s t
or Wilcoxon test, depending upon the normality of the
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Bland-Altman method was used to determine the agree-
ment between CC and CMR to assess Nakata and Mac
Goon indexes. A correlation coefficient was used to
determine the agreement between CC and CMR to
assess Nakata and Mac Goon indexes.All data were ana-
lyzed by MedCalc v.7.3.0.1.
Results
The CMR exam was completed in all patients but two:
in one patient MR angiography could not be performed
due to the impossibility of vascular access, in the other
the CMR exam was interrupted due to cough and desa-
turation. No complications occurred.
According to history, echocardiographic and CMR data
and before performing CC, 18 patients were considered
eligible for Fontan without CC, and comprised Group I.
In the other 26 patients CC was indicated (Group II) due
to one of several of the following features: ventricular
dysfunction (four patients), severe atrio-ventricular valve
regurgitation (five), significant veno-venous collaterals
(two), systemic obstruction( f o u r ) ,p u l m o n a r ya r t e r y
hypoplasia (six) and suspected pulmonary vein stenosis
(three). In one adult patient with complex congenital
heart disease who had come from abroad with no medi-
cal records, CC was indicated because of lack of exhaus-
tive clinical/instrumental information, and in another
patient because of incomplete CMR data due to technical
problems. Finally in six patients an interventional proce-
dure was planned: one aortic coarctation balloon angio-
plasty; one pulmonary bifurcation balloon angioplasty;
one LPA balloon angioplasty; one shunt embolization;
two significant venous collateral to the atrium emboliza-
tion (see Table 3 Figure 1). No Group I patient under-
went an interventional procedure.
In all study population no major complication linked
to the CC occurred. However a few minor complications
were recorded: occlusion of the femoral artery in three
patients, and a dissection of a small aorto-pulmonary
collateral occurred during angiography in one patient.
Radiation dose-Area product was not significantly dif-
ferent in the two groups (Median 20 Gycm
2, range: 5-40
in group I vs. median 26.5 Gycm
2,r a n g e9 - 2 7 0p=
0.37). The corresponding estimated lifetime attributable
risk of fatal and non-fatal cancer, based on Ionizing
Radiation Committee VII (BEIR VII) released in 2006
[22] for all combinations of age was on average 1 in 350
patient. Mean RPA and LPA pressure were slightly
higher in Group II than in Group I.
The echo exam resulted complete in only 15 pts
(34%), mainly due to inadequate mediastinal vessel
visualization. Based on echo and before MR, only 10 pts
(22%) could have been categorized as group I ("CC not
required” Group). The correlation between Nakata and
Mac Goon indexes calculated by CC and CMR was
respectively: r = 0,79, p < 0.001 and r = 0.76. P < 0.001.
Agreement evaluated by Bland Altman analysis between
Nakata and Mac Goon indexes calculated by CC and
CMR was respectively : bias = 0.086, 95% limits of
agreement = -74.6804 to 1.4540 and bias = -36.6, 95%
limits of agreement = -0.06252 to 0.2361
TTE, CMR and hemodynamic data and differences
between the two groups are summarized in Table 2.
Outcome: In Group I patients ("CC not required”
Group) CC did not add any unexpected or useful infor-
mation affecting surgical planning or indication. No
interventional procedure was performed and all 18
patients underwent a total cavo-pulmonary anastomosis.
The Fontan baffle was fenestrated in two patients due to
long bypass time; additional surgical atrio-septectomy
was performed in four patients.
In Group II ("CC required” Group) new findings were
observed at CC in three patients: a small coronary fistula,
a significant venous collateral (Figure 2), and an aorto-pul-
monary collateral, all missed by MRA. In one patient a ste-
notic pulmonary venous collector was diagnosed by MRA,
not confirmed by CC, but confirmed and corrected by the
surgeon. In the remaining patients, no unexpected findings
were revealed by X-ray angiography; however, due to the
presence of several risk factors that could interfere with
Fontan surgical planning and prognosis, CC pressure data
helped the decision-making process. As a matter of fact,
four patients from this group were excluded from Fontan
due to severe ventricular dysfunction, high pulmonary
Table 3 Percutaneous interventional procedures
Diagnosis Indication Type of procedure
HLHS Trans-isthmus gradient > 20 mmHg Balloon angioplasty
DILV SVC-LPA 2 mmHg gradient LPA balloon angioplasty
TA Significant LPA stenosis at X-ray angiography LPA balloon angioplasty
PAIVS Veno-venous collateral draining into the CS Embolization
TA Veno-venous collateral draining into the atrium Embolization
Complex 2 ventricles BTm shunt center opened at previous surgery Embolization
Legend: mBT Modified Blalock-Taussig; CS: coronary sinus; DILV: double inlet left ventricle; HLHS: hypoplastic left heart syndrome; LPA: left pulmonary artery;
PAIVS: pulmonary atresia intact ventricular septum; SVC: superior vena cava; TA: tricuspid atresia.
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Page 5 of 10Figure 1 Veno-venous collateral in a patient candidate for Fontan. A: CMR: MIP reconstruction from TOF acquisition showing a veno-
venous collateral from the SVC. B. Selective X-ray angiography in the veno-venous collateral.
Figure 2 Azygos-portal vein collateral in a patient candidate for Fontan. X-ray angiography showing an Azygos-portal vein collateral (*)
missed at MRA.
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last two; 19 patients underwent total cavo-pulmonary ana-
stomosis and in 13 of them the Fontan conduit was fene-
strated. Additional surgical procedures were performed in
7 of them: two AV valve plasty, two enlargements of the
pulmonary venous collector, one closure of right AV valve
and pulmonary artery enlargement, one right AV valve
closure and coronary fistula occlusion, and one Damus-
Kaye-Stansel procedure. Two patients are awaiting Fontan
at the time of writing, because they are still in very good
clinical condition. One adult patient refused the
intervention.
Follow-up
37 patients underwent the Fontan operation (18 from
group I, 19 from group II); 4 of them coming from abroad
were lost at follow-up; the remaining 33 patients had a
mean follow-up of 4.4 years (range 0.1-8.0). Mean periph-
eral oxygen saturation evaluated at the last ambulatory
control was 95 ± 3.9%. In three of them peripheral oxygen
saturation was < 90% and all are group II patients, as well
as three patients who experienced an adverse outcome: 1
atrial major arrhythmia, 1 reduction of functional capacity
due to low cardiac function, and 1 increased common AV
regurgitation leading to surgical replacement. One patient
from group I presented a neurological event due to throm-
boembolic complication. Finally two patients underwent
successful percutaneous closure of the conduit fenestra-
tion. Surgical date, ICU stay, post-operative complications,
follow-up and differences between the two groups are
summarized in Table 4.
Discussion
To our knowledge this is the first study where the diag-
nostic value of CC has prospectively been tested in a
pre-Fontan setting. In our study 18 patients (41% of the
entire population) have been considered eligible for Fon-
tan without prior CC. In 16 of them the CC did not add
any unexpected insight and the surgical planning did
not change after it. In the other two the CC was not
performed in accordance with the parents’ wishes and
they went to Fontan directly without prior CC. In all 18
patients the surgical procedure resulted uneventful as
did the short- term follow-up. At medium-term a neu-
rological sequel, not due to an incorrect diagnosis but
rather to coagulation mismanagement, was the only
complication occurring in one patient from group I. Of
note is also that at medium-term follow-up (4.4 ± 2.6
years) mean oxygen peripheral saturation was 97% ± 1.6
and no additional procedure was prescribed.
Conversely, CC was indicated in 26 patients (59% of
the whole population study) prior to Fontan, according
to the abovementioned criteria. This percentage is in
concordance with similar studies that retrospectively
evaluated the diagnostic value of CC (10-11). New fea-
tures were found in three patients. In the remaining
patients, although no unexpected findings emerged from
X-ray angiography, CC pressure data helped the deci-
sion-making process. In particular patients with several
risk factors that interfere with Fontan surgical planning
and prognosis, according to the algorithm proposed in
the present study, enter in the “CC required” group
such as the patients excluded from Fontan in our study.
In recent years contraindication for Fontan is a relatively
rare condition (10% in our population) and is generally
based on several parameters. At our institution exclu-
sion from Fontan is generally multifactorial and in these
cases, we believe that CC could add more information
and thus aid a difficult decision-making process. Our
results indicate that in association with more traditional
clinical, ECG and echocardiographic data, the routine
use of CMR before the Fontan procedure is of pivotal
importance. With this integrated imaging approach, CC
could be avoided in selected patients.
The aim of the diagnostic evaluation before Fontan is
to identify those few patients in whom the Fontan
operation should not be performed, and those who
require additional intervention before or at the time of
Fontan. From the literature, whether CC is necessary
before the Fontan operation remains controversial, espe-
cially when sufficient data are provided by echocardio-
graphy and CMR. The main arguments in favor of
routine CC before Fontan are assessment of pulmonary
artery pressure and vascular resistance [4] as important
prognostic factors [20,23-25]. Either potential collateral
veins between the superior vena cava and the left atrium
or peripheral pulmonary artery stenosis are also a
potential CMR caveat [4]. Moreover, CMR fails to visua-
lize very small aorto-pulmonary collaterals that,
Table 4 Fontan and post-Fontan data
All
n 37/43
Group 1
n 18/18
Group 2
n 19/26
P
Fenestrated Fontan 15 (37%) 2 (11%) 13 (69%) < 0.001
Additional procedure 11 (30%) 4 (22%) 7 (37%) 0.1
ECC time (min) 131 ± 59 108 ± 42 164 ± 65 0.003
ICU stay time (days) 3 (1-22) 2 (2-20) 4 (1-22) 0,06
Peri-op Complications:
-Low cardiac output 6 (16%) 1 (5%) 5 (26%) 0.1
-Effusion 14 (38%) 7 (39%) 7 (37%) 0.8
- Neurologic events 3 (8%) 1 (5%) 2 (10%) 0.9
-Other complications* 4 (19%) 3 (17%) 1 (5%) 0.5
02 sat. at discharge 92 ± 3.9 95 ± 2.3 90 ± 3.6 <0.001
Follow-up (years) 4.4 ± 2.2 4.4 ± 2.6 4.3 ± 2 0.8
02% sat. at Follow-up 95 ± 4 97 ± 1.6 93 ± 4.7 0.001
* two diaphragmatic paralyses; one major bleed; one major atrial arrhythmia
Legend: ECC: extracorporeal circulation; ICU: intensive care unit
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outcome after Fontan, and therefore are routinely embo-
lized [26,27]. However these findings have not been
reproduced by other studies [28] and at our institution,
coil embolization of very small systemic to pulmonary
collaterals is not routinely performed before Fontan. On
the other hand, CMR’s ability to assess pulmonary artery
and vein flow could be a unique tool, suggesting the
amount of artero-pulmonary collateral flow. Therefore
we believe that CMR is emerging as a versatile new
diagnostic imaging tool, able to give us accurate anato-
mical and functional details that are not otherwise avail-
able. With a non-invasive and radiation-free approach,
CMR can assess ventricular function and potential scar
tissue and pulmonary artero-venous flow more accu-
rately than any other diagnostic tool.
Another issue in favor of avoiding CC in all Fontan
candidates is that management strategy for patients with
a functional single ventricle has evolved to include sta-
ging bidirectional cavopulmonary anastomosis in most
cases and it has become uncommon to exclude patients
from Fontan, based on catheterization data [29]. In
these complex patients, if a standardized treatment has
been correctly followed since birth, pulmonary resis-
tance is seldom an important issue at the pre-Fontan
stage. It is of note that all but one of the patients
included in our study had already undergone assessment
of pulmonary resistance by means of a pre-Glenn CC a
few years before. Since pulmonary resistance does not
usually change after the Glenn procedure, there is no
reason to indicate CC before Fontan in such patients if
only for assessing pulmonary resistance. From a practi-
cal point of view, pulmonary pressure issues can also be
dealt with in the operating room in a pre-extracorporeal
circulation setting in close collaboration with the car-
dio-anesthesiologist, cardiologist and cardiac surgeon. In
cases of cavo-pulmonary anastomosis with additional
antegrade pulmonary flow, pulmonary pressure can be
assessed even better in the operating room than by tra-
ditional CC, due to the fact that with an open chest it is
possible to modulate or even to stop the antegrade pul-
monary artery flow.
The echo exam was considered complete in only 34%
of the patients. This relatively low percentage, confirmed
by the literature (11), is mainly due to the typically poor
visualization of the mediastinal vessels.
Clinical implications
Our results showed that CC is indicated only in selected
cases before the Fontan operation. In clinical practice
we propose a personalized diagnostic flow chart for eva-
luation of patients with functional UV heart, candidates
for Fontan circulation (Figure 3). This is supported by
better knowledge of the “non-physiologic” Fontan
circulation, deriving from more than 35 years’ experi-
ence [2] and the development of new diagnostic imaging
tools, mainly CMR. We advocate CC in selected cases
with historical or clinical/laboratory suspicion of high
pulmonary vasculature pressure and/or resistance,
including poor ventricular function and/or severe atrio-
ventricular valve insufficiency; in case of evidence or
suspected pulmonary pathway stenosis, or in case of sys-
temic obstruction; and of course when any interven-
tional procedure is indicated, as in case of suspected
aorto-pulmonary or veno-venous major collaterals, espe-
cially if potentially draining to the left atrium. The pro-
posed algorithm could serve in selected cases to avoid a
CC that, as an invasive diagnostic tool, presents some
immediate procedural risks, as well as long-term risks
linked to the radiation burden. However, the above-pro-
posed flow chart should be personalized according to
the institutional and CMR lab experience.
The routine use of pre-Fontan CC is based on over 50
years of clinical experience in CC data and x-ray. In
fact, surgeons and cardiologists are more used to explor-
ing the anatomy of the heart and vessels as well as the
hemodynamics by means of x-ray angiography, rather
than CMR, although the latter is far more informative.
This will change in the near future as CMR becomes
increasingly widespread and accepted, and as pediatric
cardiology courses increasingly include MR tuition.
Study limitation
This study is not a randomized study, and presents all
the limits of a prospective, observational, single-center
study, with a relatively low sample size. Nevertheless,
the highly selected population, the homogeneous criteria
of clinical decision-making, and access to state-of-the
art technology and expertise may provide a valuable per-
spective for evaluating these challenging patients.
This study had not been designed to test echo perfor-
mance in pre-Fontan patients, so the relatively low per-
centages of “complete echo” indicated above would have
been slightly superior if the echo exam had been
repeated by an experienced cardiologist, at least in a
second attempt if considered “not complete”.
Conclusion
In a pre-Fontan setting, an accurate clinical history and
instrumental evaluation based mainly on echo and tar-
geted cardiac CMR can screen patients suitable for Fon-
tan who could skip CC, avoiding the acute risks linked
to invasive procedures and contrast-induced nephropa-
thy. Perhaps equally important, a young patient will
avoid the long-term cancer risks connected to radiation
exposure and preserve vascular access to the heart. Fol-
lowing this flow chart in patients before Fontan, diag-
nostic CC becomes an optional procedure indicated in
Ait-Ali et al. Journal of Cardiovascular Magnetic Resonance 2011, 13:69
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fere with Fontan surgical planning and prognosis and
when interventional CC is indicated. Moreover, since
CMR can provide accurate anatomical and functional
details unavailable via any other tool, the widespread
use of this technique has great potential to offer more
detailed knowledge of Fontan “physiology”.H o w e v e r ,
since ours was a small, single-center study, and due to
lack of long-term outcomes, further studies are needed
to confirm the proposed algorithm.
Figure 3 Proposal diagnostic algorithm in patient candidates for Fontan operation. Criteria are detailed in the text. AV: Atrio-Ventricular;
MIP: Maximum Intensity Projection PVR: Pulmonary Vascular Resistance; SVC: Superior Vena Cava; TOF: Time of Flight; UVH: Univentricular Heart;
VV: Veno-Venous.
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